Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …

Background: Long-term outcomes of antiplatelet monotherapy in patients who receive
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …

Aspirin's antithrombotic effects have a long-established place in the prevention of
cardiovascular disease (CVD), and its traditional use as a core therapy for secondary …

Background: Daily low-dose aspirin increases major bleeding; however, few studies have
investigated its effect on iron deficiency and anemia. Objective: To investigate the effect of …

Objective Aspirin has been widely utilized over several decades for atherosclerotic
cardiovascular disease (ASCVD) prevention among adults in the United States. We …

Background With the aging of the population, the characterization of frailty and comorbidity
burden is increasingly taking on particular importance. The aims of the present study are to …

Platelets are the main effectors of the thrombotic events occurring at a ruptured
atherosclerotic plaque and therefore antiplatelet agents are the mainstay of antithrombotic …

Cardiovascular disease exacts a heavy toll on health and quality of life and is the leading
cause of death among people≥ 65 years of age. Although medical, surgical, and device …

Cardiovascular (CV) diseases remain a global health challenge, with ischemic heart
disease (IHD) being the primary cause of both morbidity and mortality. Despite optimal …

Coronary artery disease exhibits growing mortality and morbidity worldwide despite the
advances in pharmacotherapy and coronary intervention. Coronary artery disease is …